⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Class Action Lawsuit Filed Against MoonLake Immunotherapeutics (MLTX) - Recover Losses - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
MLTX
Investor Alert: Deadline Approaching to Join MoonLake Immunotherapeutics (MLTX) Class Action - Contact Levi & Korsinsky
accessnewswire.com
MLTX
Pomerantz LLP Informs Investors of Class Action Filing Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Shareholders of MoonLake Immunotherapeutics (MLTX): Protect Your Rights Before December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Class Action Lawsuit Alert: Levi & Korsinsky Reminds MoonLake Immunotherapeutics (MLTX) Investors of December 15, 2025 Deadline
accessnewswire.com
MLTX
MLTX COURT NOTICE: Securities Fraud Allegations Hit MoonLake Immunotherapeutics - Investors Urged to Contact BFA Law Before December 15 Leadership Deadline
accessnewswire.com
MLTX
Recover Investment Losses: Class Action Initiated Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
MLTX LAWSUIT ALERT: Levi & Korsinsky Notifies MoonLake Immunotherapeutics Investors - Lead Plaintiff Deadline December 15, 2025
accessnewswire.com
MLTX